Inhibition of the phosphatidylinositol 3’-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac. - Yip-Schneider,M.T.; Wiesenauer,C.A.; Schmidt,C.M. (J Gastrointest Surg, 2003)